vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
Ponce Financial Group, Inc. is the larger business by last-quarter revenue ($31.4M vs $19.2M, roughly 1.6× Apyx Medical Corp). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -6.8%, a 43.1% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs 34.7%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 23.7%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
APYX vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $31.4M |
| Net Profit | $-1.3M | $10.1M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 43.6% |
| Net Margin | -6.8% | 36.3% |
| Revenue YoY | 34.7% | 37.6% |
| Net Profit YoY | 71.9% | 245.6% |
| EPS (diluted) | — | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $31.4M | ||
| Q3 25 | $12.9M | $26.7M | ||
| Q2 25 | $11.4M | $26.5M | ||
| Q1 25 | $9.4M | $24.6M | ||
| Q4 24 | $14.2M | $22.8M | ||
| Q3 24 | $11.5M | $20.2M | ||
| Q2 24 | $12.1M | $20.2M | ||
| Q1 24 | $10.2M | $20.5M |
| Q4 25 | $-1.3M | $10.1M | ||
| Q3 25 | $-2.0M | $6.5M | ||
| Q2 25 | $-3.8M | $6.1M | ||
| Q1 25 | $-4.2M | $6.0M | ||
| Q4 24 | $-4.6M | $2.9M | ||
| Q3 24 | $-4.7M | $2.4M | ||
| Q2 24 | $-6.6M | $3.2M | ||
| Q1 24 | $-7.6M | $2.4M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 43.6% | ||
| Q3 25 | -6.5% | 32.8% | ||
| Q2 25 | -22.6% | 30.2% | ||
| Q1 25 | -32.4% | 32.5% | ||
| Q4 24 | -21.4% | 19.6% | ||
| Q3 24 | -31.6% | 15.2% | ||
| Q2 24 | -45.7% | 21.8% | ||
| Q1 24 | -64.6% | 18.3% |
| Q4 25 | -6.8% | 36.3% | ||
| Q3 25 | -15.4% | 24.3% | ||
| Q2 25 | -33.2% | 23.0% | ||
| Q1 25 | -44.0% | 24.2% | ||
| Q4 24 | -32.5% | 14.1% | ||
| Q3 24 | -40.9% | 12.1% | ||
| Q2 24 | -54.0% | 15.8% | ||
| Q1 24 | -74.0% | 11.8% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | — | $0.27 | ||
| Q2 25 | — | $0.25 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $0.11 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | $-0.19 | $0.14 | ||
| Q1 24 | $-0.22 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $126.2M |
| Total DebtLower is stronger | $37.5M | $596.1M |
| Stockholders' EquityBook value | $14.5M | $541.5M |
| Total Assets | $66.8M | $3.2B |
| Debt / EquityLower = less leverage | 2.58× | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $126.2M | ||
| Q3 25 | $25.1M | $146.6M | ||
| Q2 25 | $29.3M | $126.6M | ||
| Q1 25 | $31.0M | $129.9M | ||
| Q4 24 | $31.7M | $139.8M | ||
| Q3 24 | $28.0M | $155.8M | ||
| Q2 24 | $32.7M | $103.2M | ||
| Q1 24 | $37.3M | $134.7M |
| Q4 25 | $37.5M | $596.1M | ||
| Q3 25 | $37.5M | $521.1M | ||
| Q2 25 | $37.5M | $536.1M | ||
| Q1 25 | $37.5M | $521.1M | ||
| Q4 24 | $37.5M | $596.1M | ||
| Q3 24 | $37.5M | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $14.5M | $541.5M | ||
| Q3 25 | $5.8M | $529.8M | ||
| Q2 25 | $7.3M | $521.1M | ||
| Q1 25 | $10.5M | $513.9M | ||
| Q4 24 | $14.2M | $505.5M | ||
| Q3 24 | $11.0M | $504.6M | ||
| Q2 24 | $14.7M | $497.7M | ||
| Q1 24 | $20.3M | $493.7M |
| Q4 25 | $66.8M | $3.2B | ||
| Q3 25 | $57.4M | $3.2B | ||
| Q2 25 | $58.2M | $3.2B | ||
| Q1 25 | $60.2M | $3.1B | ||
| Q4 24 | $64.8M | $3.0B | ||
| Q3 24 | $60.7M | $3.0B | ||
| Q2 24 | $65.4M | $2.8B | ||
| Q1 24 | $70.7M | $2.8B |
| Q4 25 | 2.58× | 1.10× | ||
| Q3 25 | 6.41× | 0.98× | ||
| Q2 25 | 5.17× | 1.03× | ||
| Q1 25 | 3.57× | 1.01× | ||
| Q4 24 | 2.64× | 1.18× | ||
| Q3 24 | 3.40× | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $55.6M |
| Free Cash FlowOCF − Capex | $-2.8M | $54.6M |
| FCF MarginFCF / Revenue | -14.6% | 173.9% |
| Capex IntensityCapex / Revenue | 1.4% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $55.6M | ||
| Q3 25 | $-3.5M | $1.4M | ||
| Q2 25 | $-1.2M | $6.2M | ||
| Q1 25 | $-702.0K | $13.1M | ||
| Q4 24 | $-2.9M | $7.2M | ||
| Q3 24 | $-4.4M | $-14.6M | ||
| Q2 24 | $-4.3M | $-2.6M | ||
| Q1 24 | $-6.3M | $1.5M |
| Q4 25 | $-2.8M | $54.6M | ||
| Q3 25 | $-4.1M | $786.0K | ||
| Q2 25 | $-1.5M | $5.9M | ||
| Q1 25 | $-757.0K | $12.9M | ||
| Q4 24 | $-3.2M | $4.5M | ||
| Q3 24 | $-4.6M | $-15.0M | ||
| Q2 24 | $-4.6M | $-2.6M | ||
| Q1 24 | $-6.4M | $-315.0K |
| Q4 25 | -14.6% | 173.9% | ||
| Q3 25 | -31.5% | 2.9% | ||
| Q2 25 | -13.2% | 22.4% | ||
| Q1 25 | -8.0% | 52.6% | ||
| Q4 24 | -22.4% | 19.7% | ||
| Q3 24 | -40.0% | -74.1% | ||
| Q2 24 | -38.0% | -13.0% | ||
| Q1 24 | -62.2% | -1.5% |
| Q4 25 | 1.4% | 3.1% | ||
| Q3 25 | 4.0% | 2.3% | ||
| Q2 25 | 2.3% | 1.0% | ||
| Q1 25 | 0.6% | 0.6% | ||
| Q4 24 | 1.7% | 11.9% | ||
| Q3 24 | 1.3% | 2.0% | ||
| Q2 24 | 2.4% | 0.3% | ||
| Q1 24 | 0.3% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
